Zalvin v. Gentex Corporation

CourtDistrict Court, E.D. New York
DecidedMay 18, 2020
Docket1:19-cv-02215
StatusUnknown

This text of Zalvin v. Gentex Corporation (Zalvin v. Gentex Corporation) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Zalvin v. Gentex Corporation, (E.D.N.Y. 2020).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK -----------------------------------------------------------------x JOEL ZALVIN, Plaintiff, MEMORANDUM AND ORDER - against - 19-CV-2215 (RRM) (RML)

GENTEX CORPORATION, Defendant. -----------------------------------------------------------------x ROSLYNN R. MAUSKOPF, United States District Judge. Plaintiff Joel Zalvin voluntarily dismissed this shareholder derivative action after defendant Gentex Corporation (“Gentex”) took the action demanded in the complaint, thereby mooting Zalvin’s case. Zalvin then moved, “pursuant to Federal Rule of Civil Procedure 54(d)(2) and pursuant to the Court’s inherent power to award attorneys’ fees,” to recover the expenses of prosecuting this action, including attorney’s fees. (Notice of Plaintiff’s Motion for an Award of Attorney’s Fees (Doc. No. 15) at 2.) In a letter motion dated May 24, 2019, Gentex now moves to strike that motion, relying on two district court opinions from the Ninth Circuit which hold that fees cannot be awarded under Rule 54 absent a “judgment,” and that a notice or stipulation of dismissal does not constitute a “judgment” as defined in Rule 54(a). For the reasons set forth below, Gentex’s motion is denied and Zalvin’s motion for attorney’s fees is referred to Magistrate Judge Levy to hear and determine. BACKGROUND On April 16, 2019, Zalvin commenced this shareholder derivative action against Gentex under section 14(a) of the Securities Exchange Act of 1934, 15 U.S.C. § 78n(a), alleging that a proposal in Gentex’s proxy statement which sought shareholder approval of the corporation’s “2019 Omnibus Incentive Plain” failed to comply with the disclosure requirements of Schedule 14A promulgated under the Securities Exchange Act of 1934, 17 C.F.R. § 240.14A-101. (Complaint (Doc. No. 1) at ¶¶ 1–2.) Zalvin’s complaint sought, among other things, a mandatory injunction requiring Gentex to “furnish a supplemental proxy statement with the information required by [Schedule 14A].” (Id. at 7.) Zalvin also sought an award of “reasonable attorney’s fees and expenses incurred in bringing this action and creating a benefit for all of Gentex’s shareholder to the extent that a common benefit is incurred.” (Id.) On April 23, 2020, less than ten days after the complaint was filed, Gentex issued a

supplemental disclosure of the sort requested in Zalvin’s complaint. (Memorandum of Law in Support of Plaintiff’s Motion for Attorney’s Fees (Doc. No. 15-1) at 3.) On May 6, 2020, recognizing that his action had become moot, Zalvin voluntarily dismissed the action pursuant to Rule 41(a) of the Federal Rules of Civil Procedure. (Id.; Notice of Voluntary Dismissal (Doc. No. 14).) Fourteen days later, Zalvin moved for an award of attorney’s fees “pursuant to Federal Rule of Civil Procedure 54(d)(2) and pursuant to the Court’s inherent power to award attorneys’ fees,” asserting that this action “conferred a substantial benefit upon Gentex and its shareholders by, inter alia, curing a violation of the Securities Exchange Act of 1934.” (See Notice of Plaintiff’s Motion for an Award of Attorney’s Fees (Doc. No. 15) at 2.) In a letter dated May 24, 2020, Gentex now moves to strike Zalvin’s motion for

attorney’s fees on two grounds. (Letter Motion (Doc. No. 16).) First, Gentex argues that Zalvin ignored the Court’s Individual Rules by failing to seek permission to bring the motion. (Id. at 1– 2.) Second, Gentex argues that Zalvin cannot move for attorney’s fees under Rule 54 of the Federal Rules of Civil Procedure because a judgment was never entered in this case. (Id. at 2–3.) In support of the latter proposition, Gentex principally relies on two cases decided by district courts in the Ninth Circuit – Physician’s Surrogacy, Inc. v. German, 311 F. Supp. 3d 1190 (S.D. Cal. 2018), and Keith Mfg., Co. v. Butterfield, 256 F. Supp. 3d 1123 (D. Or. 2017) – which held that a “judgment,” as defined in Rule 54(a) is a prerequisite to an award of attorney’s fees under Rule 54. (Letter Motion at 2.) Gentex also cites to the Supreme Court’s decision in Microsoft v. Baker, 137 S. Ct. 1702 (2017), and to the Second Circuit’s decision United States v. L-3 Commc’ns EOTech, Inc., 921 F.3d 11 (2d Cir. 2019), for the proposition that voluntary dismissal is appealable and, therefore, not a “judgment.” (Letter Motion at 2–3.) DISCUSSION A. Zalvin followed the Court’s Individual Rules

Gentex’s first argument misconstrues the Court’s Individual Rules. These rules require that a prospective movant request a pre-motion conference prior to filing “any dispositive motion, motion for a change of venue, or motion to amend a pleading pursuant to Federal Rule of Civil Procedure 15.” Individual Rules § III.A.2. They do not require that a prospective movant seek permission to file a post-trial motion. Id. § III.A.4 (“No pre-motion conference shall be required for post-trial motions.”). Accordingly, Gentex was not required to request a pre-motion conference or briefing schedule prior to filing its motion for attorney’s fees. B. Zalvin’s Voluntary Dismissal does not Preclude an Award of Attorney’s Fees Although Zalvin’s Notice of Motion for an Award of Attorney’s Fees states that the motion is brought “pursuant to Federal Rule of Civil Procedure 54(d)(2),” (Notice of Motion at

1), that rule does not provide the sole basis for relief. Indeed, the Notice of Motion further states that the motion is also brought “pursuant to the Court’s inherent power to award attorney’s fees, because his prosecution of this Action has conferred a substantial benefit upon Gentex and its shareholders ….” (Id. at 1–2.) This language implies that Zalvin is not only pursuing attorney’s fees under the law – Rule 54 – but also pursuing equitable relief under the “common benefit doctrine.” “In the United States, the prevailing litigant is ordinarily not entitled to collect a reasonable attorneys’ fee from the loser.” Alyeska Pipeline Serv. Co. v. Wilderness Soc’y, 421 U.S. 240, 247 (1975). “Since the nineteenth century, however, the Supreme Court has recognized an equitable exception to this rule – known as the common fund or common benefit doctrine – that permits litigants or lawyers who recover a common fund for the benefit of persons other than themselves to obtain reasonable attorney’s fees ….” In re Zyprexa Prod. Liab. Litig., 594 F.3d 113, 128 (2d Cir. 2010). This doctrine arises from the equitable doctrine of unjust enrichment, since “[t]o allow the others to obtain full benefit from the plaintiff’s efforts without

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Zyprexa Products Liability Litigation
594 F.3d 113 (Second Circuit, 2010)
Mills v. Electric Auto-Lite Co.
396 U.S. 375 (Supreme Court, 1970)
Alyeska Pipeline Service Co. v. Wilderness Society
421 U.S. 240 (Supreme Court, 1975)
New Leadership Committee v. Davidson
23 F. Supp. 2d 301 (E.D. New York, 1998)
Microsoft Corp. v. Baker
582 U.S. 23 (Supreme Court, 2017)
Xlear, Inc. v. Focus Nutrition, LLC
893 F.3d 1227 (Tenth Circuit, 2018)
United States v. L-3 Communications EOTech, Inc.
921 F.3d 11 (Second Circuit, 2019)
Keith Manufacturing, Co. v. Butterfield
256 F. Supp. 3d 1123 (D. Oregon, 2017)
Physician's Surrogacy, Inc. v. German
311 F. Supp. 3d 1190 (S.D. California, 2018)
Lewis v. Anderson
692 F.2d 1267 (Ninth Circuit, 1982)
Koppel v. Wien
743 F.2d 129 (Second Circuit, 1984)

Cite This Page — Counsel Stack

Bluebook (online)
Zalvin v. Gentex Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/zalvin-v-gentex-corporation-nyed-2020.